Rigel Pharmaceuticals | Debitur Perdagangan

Harga Saham
32.96
Perubahan Harian
-1.66 -4.79%
Bulanan
-5.69%
Tahunan
49.28%
Q1 Perkiraan
33.68




Debitur Perdagangan Perubahan Tanggal
Agenus USD 354K 53K 2025-03
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celldex Therapeutics USD 2.02M 1.92M 2025-12
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 67.04M 6.9M 2024-09
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 69.23M 56.7M 2025-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Veracyte USD 44.66M 3.17M 2025-12


Rigel Pharmaceuticals Debitur Perdagangan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2026.